Wouter J de Jonge
Prof. dr. Wouter de Jonge, AGAF, received his doctoral training at University of Utrecht, and Columbia University New York, and received his PhD in 2001 (Medicine, University of Amsterdam and Maastricht). He took up postdoctoral positions at the AMC in Amsterdam (prof Guy Boeckxstaens-now in Leuven) and Oxford University (prof Siamon Gordon). He was appointed tenured assistant professor at Amsterdam UMC in 2009 and was appointed full professor in 2013. He currently chairs the gastro-intestinal research group (www.gut-research.com) at the Amsterdam UMC since 2013 and holds a part time professorship at the Dept of Surgery at the University of Bonn, Germany since 2018.
His work focusses on translational gastroenterology and the pathology of IBD. He is interested in gastrointestinal physiology and the function of neural networks within the gastrointestinal tract, in particular in relation to IBS and IBD. His work is funded via national Science Foundation grants (NWO-Vidi-STW), EU FP7, ECCO, and 2 Horizon2020 grants, Helmsley Foundation, Health Holland TKI topsector grants, and various public private partnership grants. He was co-founder of the Microbiome Center Amsterdam in 2016. He holds 5 patents. He served on the board of the scientific committees a.o. Dutch national trust for Gastro Intestinal and Lever Diseases, EU Marie Curie grants, AMC Valorisation Board, and serves as CEO on a spin off company AI-Biomics B.V., a company that develops predictive algorithms for disease biomarkers.
Sophie Durand
Niall Hyland
Michèle Paquier
Michèle has 15+ years of experience in the biotech field, mostly genome engineering, where she has developed IP strategy, managing know-how and large international patents portfolio to support research, commercial and legal activities as a true business partner.
Michèle is heading the IP activity of Eligo Bioscience, a biotech company developing a first-in-class proprietary technology to engineer the microbiome and change the genetic signature of the microbiome with unprecedented precision.
In the past, Michèle worked over 6 years with Cellectis, a pioneering biotech company in genome engineering. She is also a former IP expert of Bpifrance (French Public Investment Bank).
Jose A Villa Rodriguez
Christopher Carite
Christophe is a French citizen graduated in industrial pharmacy (PharmD), Microbiology and Business Administration. He has started his industrial career as plant manager for Lallemand Bacteria Division early ninety, then occupied various positions in R&D and Marketing in B2B of Pharmaceuticals Ingredients. He has joined 4D pharma at the early beginning of the company in 2014 and he has assumed the challenge to produce freeze dried strict anaerobic bacteria at the industrial scale level ( 3500 L fermentor, 5 to 20m2 Freeze dryer) to deliver high concentrated LBPs to patients (> 1010 CFU/caps, shelf life up to 2 years) recognised by several patent families granted. In addition, Christophe has integrated “in house” all 4D pharma Manufacturing and Controls under inspected cGMP.
Right now, he assume the position of Process development/CMC Director and member of 4D Pharma Executive team reporting directly to the CEO.
Céline Durant
Adam Baker
